In a report released today, Patrick Sholl from Barrington maintained a Hold rating on CuriosityStream (CURI – Research Report). The company’s shares closed yesterday at $2.11. Effectively ...

Feb. 26 (UPI) --Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the United States and make the nation the world's leader in ...

Q1 2025 Revenue Guidance: Expected in the range of $14.5 to $15.5 million. CuriosityStream Inc (NASDAQ:CURI) achieved a significant year-over-year cash flow increase of $26 million in 2024.

Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive — and covered an exclusive trip for leaders to attend last summer’s ...

The image of Israeli hostage Eli Sharabi being released from Gaza a little over two weeks ago, looking gaunt and weak, shocked and angered Israel and leaders around the world. His brother Sharon ...

CuriosityStream Inc. (CURI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.09 per share a year ago.

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

This regularly scheduled sponsored column is written by Eli Tucker, Arlington-based Realtor and Arlington resident. If you would like to work with Eli and his team in Northern Virginia and the ...

Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the U.S. The drugmaker, which had committed to $23 billion in domestic investments from 2020 ...

Eli Lilly LLY-0.69%decrease; red down pointing triangle is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using their health plans, and ...